We report *Wohlfahrtiimonas chitiniclastica* bacteremia in a 75-year-old man in Japan who had squamous cell carcinoma on his shoulder. In September 2016, an unidentified patient was found unconscious on the ground by a passerby and admitted to the emergency department of the National Center for Global Health and Medicine (Tokyo, Japan). He had a necrotic lesion on his left shoulder with maggots. Blood analysis showed leukocytosis (26.61 × 10^9^ cells/L \[reference range 3.30--8.60 × 10^9^ cells /L\]), thrombocytosis (626 × 10^9^/L \[reference range 158--348 × 10^9^/L\]), anemia (hemoglobin, 9.6 g/dL \[reference range 13.7--6.8 g/dL\]), and elevated C-reactive protein (87.9 mg/L \[reference range 0.00--1.40 mg/L\]). Albumin was 2.4 g/dL (reference range 4.1--5.1 g/dL) and calcium was 12.6 mg/dL (reference range 8.8--10.1 mg/dL). He was diagnosed with disturbance of consciousness caused by hypercalcemia and was hospitalized.

After saline infusion and intravenous cefazolin (3 g/d) were initiated, the patient's condition improved. A blood culture taken at the time of admission grew *Peptoniphilus harei*. A swab culture of the ulcer site grew *Proteus mirabilis*, *Morganella morganii*, and *Kerstersia gyiorum*. A biopsy was performed on day 3, and the patient was diagnosed with squamous cell carcinoma. Enhanced computed tomography scanning revealed an ulcer and ring-enhancing lesion on his left shoulder (which was suspected of being a tumor or abscess) and multiple enlarged lymph nodes and 10-mm pulmonary nodules in the right lung.

On day 20, the patient had fever and disturbance of consciousness; therefore, he was transferred to the Infectious Disease department of the hospital. Intravenous therapy with vancomycin (1.5 g/d), cefepime (3 g/d), and metronidazole (1,500 mg/d) was initiated, and the patient's fever and consciousness improved. Two cultures of blood taken on day 20 grew *P. mirabilis*, *M. morganii*, *Streptococcus anginosus*, *Streptococcus agalactiae*, *Bacteroides fragilis*, and gram-negative rods. After we obtained the culture results, vancomycin was stopped in accordance with the susceptibility test results. We identified the gram-negative rods as *W. chitiniclastica* by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Bruker Daltonics, Billerica, MA, USA), which showed scores of 2.239. We further confirmed the isolate to be *W. chitiniclastica* by using 16S rRNA sequencing; the isolate was 99.08% identical to strain S5 (GenBank accession no. AM397063). We assessed the isolate's antimicrobial susceptibility profile ([Table](#T1){ref-type="table"}). The patient improved and was later discharged to another hospital.

###### Antimicrobial susceptibility profile of *Wohlfahrtiimonas chitiniclastica* from a blood culture from a patient treated at the National Center for Global Health and Medicine, Tokyo, Japan, 2016.

  Antimicrobial drug              MIC, mg/L susceptibility profile
  ------------------------------- ----------------------------------
  Piperacillin                                ≤8, S
  Piperacillin/tazobactam                     ≤8, S
  Ceftazidime                                 ≤4, S
  Cefepime                                    ≤2, S
  Aztreonam                                   ≤4, S
  Imipenem/cilastatin                         ≤1, S
  Meropenem                                   ≤1, S
  Amikacin                                    ≤8, S
  Gentamicin                                  ≤2, S
  Tobramycin                                  ≤2, S
  Minocycline                                 ≤2, S
  Levofloxacin                                1, S
  Ciprofloxacin                               1, S
  Trimethoprim/sulfamethoxazole               ≤2, S

\*S, susceptible.

*W. chitiniclastica* is a gram-negative, short, facultative anaerobic, straight-rod gammaproteobacterium that was first isolated from the parasitic fly *Wohlfahrtia magnifica* ([@R1]). This fly has not been reported in Japan. However, *W. chitiniclastica* has also been isolated from the *Chrysomya megacephala* fly, and this species has been reported in Japan ([@R2]), and from from the *Musca domestica* housefly, which is widely distributed all over the world ([@R3]). Campisi et al. reported that the *Lucilia sericata* fly might be a vector for *W. chitiniclastica* ([@R4]); this fly is common and widely distributed throughout Japan, and a case of cutaneous myiasis on skin cancer was reported ([@R5]). Unfortunately, we could not collect maggots from this patient because they were rapidly discarded at the emergency department.

Worldwide, few human cases of *W. chitiniclastica* infection have been documented. *W. chitiniclastica* has been described as a zoonotic pathogen ([@R6]) and reported from Hungary, Egypt, Niger, Germany, India, France, China, Argentina, Estonia, the United Kingdom, and the United States ([@R4]*,*[@R7]*,*[@R8]). Rebaudet et al. ([@R9]) described the first human case of bacteremia attributable to *W. chitiniclastica,* which occurred in a 60-year-old homeless woman from southeastern France who had a history of alcoholism. Other human cases of *W. chitiniclastica* bacteremia were reported from Argentina ([@R10]) and the United Kingdom ([@R4]). Recently, a bacteremia case in a 72-year-old man was reported from Hawaii, USA ([@R1]).

Risk factors for *W. chitiniclastica* infection are poor personal hygiene, alcoholism, peripheral vascular disease, and chronic open wound ([@R8]). The patient we describe had a chronic wound because of squamous cell carcinoma, and the associated maggots were thought to be the transmission route. At admission, blood and swab cultures grew polymicrobial isolates without *W. chitiniclastica,* as confirmed by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. However, a blood culture on day 20 was positive for *W. chitiniclastica*. The patient probably was infected with *W. chitiniclastica* during hospitalization. Cases of *W. chitiniclastica* infection (with or without bacteremia) were reported as parts of polymicrobial infections ([@R1]*,*[@R4]*,*[@R7]*,*[@R8]). *W. chitiniclastica* might have first infected this patient's ring-enhancing lesion as part of a polymicrobial infection. Because *W. chitiniclastica* was undetected in blood and swab cultures at admission, the organism might have entered the bloodstream during hospitalization.

This patient improved after intravenous therapy with cefepime and metronidazole. Previously reported *W. chitiniclastica* bacteremia cases were treated with combination antimicrobial therapies, including cefuroxime plus metronidazole plus clarithromycin ([@R4]), ceftazidime plus amikacin ([@R10]), piperacillin/tazobactam plus clindamycin plus vancomycin ([@R1]), ceftriaxone monotherapy ([@R9]), and meropenem monotherapy ([@R1]). Two of the 5 cases were fatal ([@R1],[@R10]).

Clinicians should be attentive to the possibility of *W. chitiniclastica* infection in patients who have chronic wounds with maggots and poor hygiene. Clinical suspicion is warranted even if blood and swab cultures are initially negative for *W. chitiniclastica*.
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